| 261 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
Department of Medical Oncology |
2021 |
| 262 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
Department of Medical Oncology |
2021 |
| 263 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
Department of Clinical Pathology |
2021 |
| 264 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
Department of Clinical Pathology |
2021 |
| 265 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
Department of Pediatric Oncology |
2021 |
| 266 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
Department of Pediatric Oncology |
2021 |
| 267 |
Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study |
Department of Pathology |
2021 |
| 268 |
Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study |
Department of Pathology |
2021 |
| 269 |
Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study |
Department of Medical Oncology |
2021 |
| 270 |
Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study |
Department of Medical Oncology |
2021 |
